Top Markets
Coin of the day
TME Pharma N.V. TME Pharma N.V.

TME Pharma N.V.

ALTME
株式のランク #33661
TME Pharma N.V., a biopharmaceutical company in the clinical development stage... TME Pharma N.V., a biopharmaceutical company in the clinical development stage based in Berlin, Germany, is dedicated to pioneering innovative therapeutic solutions for cancer. The company leverages its unique Spiegelmer platform to advance a pipeline of investigational drug candidates. Its primary oncology asset, NOX-A12, is currently being evaluated in clinical studies as a combination therapy for a range of challenging cancers, including metastatic pancreatic and colorectal cancer, glioblastoma, and myeloma. Beyond its cancer-focused efforts, TME Pharma also developed NOX-E36, which has successfully concluded Phase 1/2 clinical trials for diabetic nephropathy. The company has formed a strategic collaboration with Merck Sharp & Dohme Corp. to explore NOX-A12 in combination with Keytruda and two different chemotherapy protocols as a second-line intervention for patients battling metastatic pancreatic cancer. Founded in 1997, the organization adopted its current name, TME Pharma N.V., in July 2022, having previously operated as NOXXON Pharma N.V.
株価
$0.07591393
最終同期: 2026-08-14
時価総額
$7.15M
変化(1日)
3.90%
変化(1年)
-41.05%
DE
取引 TME Pharma N.V. (ALTME)

カテゴリー

TME Pharma N.V.(ALTME)の株価履歴
終値の最高値: $0.07 (2026-08-01)

終値の最安値: $2.42K (2016-09-01)
TME Pharma N.V. の株価履歴(2016 ~ 2026)
年間株価パフォーマンス
パフォーマンス
2026 (TTM) 32.43%
2025 -15.09%
2024 -67.73%
2023 -81.54%
2022 -95.65%
2021 -45.73%
2020 27.62%
2019 -67.02%
2018 -81.06%
2017 -65.91%
2016 0.00%
類似企業または競合の株価
企業 株価 変化率 1年%
$505.24 28.63%
US
$846.09 29.41%
NL
$731.69 6.47%
CH
$1.07K -6.40%
KR
$251.82 11.75%
BE